Johnson & Johnson acquires robotic systems developer Orthotaxy: 5 things to know

Written by Shayna Korol | February 20, 2018 | Print  |

Johnson & Johnson, through French affiliate Apsis S.A.S, acquired Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a robotic-assisted surgery solution.

Here are five things to know:


1. Orthotaxy's proprietary technology is currently in early-stage development for total and partial knee replacement. J&J plans to broaden its application for a range of orthopedic surgery procedures.


2. J&J aims to build a robotic-assisted orthopedic surgery solution that is cost-effective, time-efficient and user-friendly in a variety of care settings.


3. Moving forward, J&J will focus on digital technology solutions across the full continuum of care.


4. Robotics entrepreneur Stéphane Lavallée founded Orthotaxy.


5. Financial terms of the transaction will not be disclosed.


More articles on devices and implants:

5 things to know about NuVasive CEO Greg Lucier

5 factors influencing Stryker's success

250th implantation with Nexxt Spine's interbody system — 5 highlights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers